128 related articles for article (PubMed ID: 20019131)
1. Primary breast carcinoma: association of mammographic calcifications with osteopontin expression.
Wang X; Chao L; Ma G; Chen L; Jin G; Hua M; Liu H; Ouyang A; Zhang X
Radiology; 2010 Jan; 254(1):69-78. PubMed ID: 20019131
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.
Wang Y; Ikeda DM; Narasimhan B; Longacre TA; Bleicher RJ; Pal S; Jackman RJ; Jeffrey SS
Radiology; 2008 Feb; 246(2):367-75. PubMed ID: 18180338
[TBL] [Abstract][Full Text] [Related]
3. Correlation of mammographic calcifications with Her-2/neu overexpression in primary breast carcinomas.
Wang X; Chao L; Chen L; Tian B; Ma G; Zang Y; Hua M; Sun J
J Digit Imaging; 2008 Jun; 21(2):170-6. PubMed ID: 18256879
[TBL] [Abstract][Full Text] [Related]
4. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.
Tabar L; Tony Chen HH; Amy Yen MF; Tot T; Tung TH; Chen LS; Chiu YH; Duffy SW; Smith RA
Cancer; 2004 Oct; 101(8):1745-59. PubMed ID: 15386334
[TBL] [Abstract][Full Text] [Related]
5. Negative estrogen-receptor invasive breast carcinoma: mammographic aspects, correlations with HER2/neu oncoprotein status.
Enache DE; Georgescu CV; Pătrană N
Rom J Morphol Embryol; 2012; 53(3 Suppl):755-62. PubMed ID: 23188436
[TBL] [Abstract][Full Text] [Related]
6. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.
Jiang L; Ma T; Moran MS; Kong X; Li X; Haffty BG; Yang Q
Anticancer Res; 2011 Jun; 31(6):2327-34. PubMed ID: 21737659
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
8. Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients.
Zheng K; Tan JX; Li F; Wei YX; Yin XD; Su XL; Li HY; Liu QL; Ma BL; Ou JH; Li H; Yang SS; Jiang AM; Ni Q; Liu JL; Liu JP; Zheng H; Song ZJ; Wang L; He JJ; Zou TN; Jiang J; Ren GS
Breast Cancer Res Treat; 2017 Nov; 166(2):569-582. PubMed ID: 28770448
[TBL] [Abstract][Full Text] [Related]
9. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
[TBL] [Abstract][Full Text] [Related]
10. Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. worse prognosis for cases presenting as calcifications alone.
Thurfjell E; Thurfjell MG; Lindgren A
Breast Cancer Res Treat; 2001 May; 67(2):177-80. PubMed ID: 11519866
[TBL] [Abstract][Full Text] [Related]
11. Mammographic features of local recurrence after conservative surgery and radiation therapy: comparison with that of the primary tumor.
Günhan-Bilgen I; Oktay A
Acta Radiol; 2007 May; 48(4):390-7. PubMed ID: 17453518
[TBL] [Abstract][Full Text] [Related]
12. Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.
Bae MS; Moon WK; Chang JM; Cho N; Park SY; Won JK; Jeon YK; Moon HG; Han W; Park IA
Eur Radiol; 2013 Aug; 23(8):2072-8. PubMed ID: 23512196
[TBL] [Abstract][Full Text] [Related]
13. Calcifications in digital mammographic screening: improvement of early detection of invasive breast cancers?
Weigel S; Decker T; Korsching E; Hungermann D; Böcker W; Heindel W
Radiology; 2010 Jun; 255(3):738-45. PubMed ID: 20501713
[TBL] [Abstract][Full Text] [Related]
14. Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening.
Doyle S; Evans AJ; Rakha EA; Green AR; Ellis IO
Radiology; 2009 Oct; 253(1):51-5. PubMed ID: 19703859
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
[TBL] [Abstract][Full Text] [Related]
16. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.
Yang WT; Dryden M; Broglio K; Gilcrease M; Dawood S; Dempsey PJ; Valero V; Hortobagyi G; Atchley D; Arun B
Breast Cancer Res Treat; 2008 Oct; 111(3):405-10. PubMed ID: 18026834
[TBL] [Abstract][Full Text] [Related]
17. Nonpalpable breast cancer: mammographic appearance as predictor of histologic type.
Thurfjell MG; Lindgren A; Thurfjell E
Radiology; 2002 Jan; 222(1):165-70. PubMed ID: 11756721
[TBL] [Abstract][Full Text] [Related]
18. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas.
Seo BK; Pisano ED; Kuzimak CM; Koomen M; Pavic D; Lee Y; Cole EB; Lee J
Acad Radiol; 2006 Oct; 13(10):1211-8. PubMed ID: 16979070
[TBL] [Abstract][Full Text] [Related]
19. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.
Ma H; Luo J; Press MF; Wang Y; Bernstein L; Ursin G
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):479-85. PubMed ID: 19190139
[TBL] [Abstract][Full Text] [Related]
20. Pure and mixed mucinous carcinoma of the breast: pathologic basis for differences in mammographic appearance.
Wilson TE; Helvie MA; Oberman HA; Joynt LK
AJR Am J Roentgenol; 1995 Aug; 165(2):285-9. PubMed ID: 7618541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
